Full Press Release Details
three year results for eylea hd aflibercept injection 8 mg demonstrate continued durable vision gains and anatomic improvements with extended dosing intervals in patients with diab.
REGN
three year results for eylea hd aflibercept injection 8 mg demonstrate continued durable vision gains and anatomic improvements with extended dosing intervals in patients with diab
Key Takeaway: three year results for eylea hd aflibercept injection 8 mg demonstrate continued durable vision gains and anatomic improvements with extended dosing intervals in patients with diab